Related Experiment Video
Updated: Jul 1, 2025
05:25
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
19.2K
Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national
Tsung-Yen Lin1,2, I-Hung Chen1, Han-Yu Weng2
1Division of Urology, Department of Surgery, National Cheng Kung University Hospital Dou-Liou Branch, Yunlin, Taiwan.
World Journal of Urology
|March 9, 2024
Summary
Chronic prostatitis (CP) significantly increases the risk of developing benign prostatic hyperplasia (BPH) later in life. Younger men diagnosed with CP face an even greater risk of subsequent BPH development.
Area of Science:
- Urology
- Public Health
- Epidemiology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Chronic prostatitis (CP) is an inflammatory condition of the prostate gland.
- The relationship between CP and the risk of developing BPH requires further investigation.
Purpose of the Study:
- To investigate the association between a prior diagnosis of chronic prostatitis (CP) and the subsequent risk of developing benign prostatic hyperplasia (BPH).
Main Methods:
- Utilized Taiwan's National Health Insurance medical claims data from 2010-2017.
- Enrolled 3571 patients diagnosed with CP, excluding those with prior BPH or related conditions.
- Age-matched controls (1:4 ratio) were selected, and follow-up extended to 2018 using Cox regression analysis.
Main Results:
- Patients with CP showed a significantly higher incidence of BPH (8.03% vs. 0.43%) compared to controls.
- A covariate-adjusted hazard ratio (aHR) of 4.30 indicated a substantially increased risk of BPH in CP patients.
- Younger CP patients (20-39 years) exhibited a markedly higher risk (aHR: 11.45).
Conclusions:
- Chronic prostatitis is a significant risk factor for the later development of benign prostatic hyperplasia.
- The risk of BPH is disproportionately higher in younger individuals diagnosed with CP.
- Findings highlight the importance of considering CP in the management and risk assessment for BPH.
